Teachers Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Teachers Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$388K	Buy	4,242 +477	+13%	+$33.2K	﹤0.01%	2643
2018 Q4	$210K	Hold	3,765	–	–	﹤0.01%	2835
2018 Q3	$448K	Sell	3,765 -23	-0.6%	-$2.67K	﹤0.01%	2682
2018 Q2	$387K	Buy	3,788 +1,516	+67%	+$188K	﹤0.01%	2765
2018 Q1	$295K	Hold	2,272	–	–	﹤0.01%	2761
2017 Q4	$221K	Hold	2,272	–	–	﹤0.01%	2898
2017 Q3	$334K	Hold	2,272	–	–	﹤0.01%	2767
2017 Q2	$366K	Buy	2,272 +1,779	+361%	+$279K	﹤0.01%	2755
2017 Q1	$79K	Hold	493	–	–	﹤0.01%	3002
2016 Q4	$60K	Hold	493	–	–	﹤0.01%	3049
2016 Q3	$68K	Buy	+493	New	+$62.6K	﹤0.01%	3035

Other funds holding SYRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Teachers Advisors's SYRS Position: Q1 2019 in Review

Teachers Advisors increased its Syros Pharmaceuticals, Inc. Common Stock (SYRS) stake by 13% in Q1 2019, buying an estimated $33.2K and bringing the position to 4,242 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #2643.

Teachers Advisors first reported a position in SYRS in Q3 2016 and has held it in 11 quarters since. The position peaked at $448K in Q3 2018. 65 funds tracked by Wall St. Rank hold SYRS as of Q1 2019.

Teachers Advisors held 4,242 shares of Syros Pharmaceuticals, Inc. Common Stock worth $388K as of Q1 2019.
Teachers Advisors bought 477 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $33.2K.
Syros Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2643 holding.
Teachers Advisors first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2016 and has held it in 11 quarters since.
Teachers Advisors's Syros Pharmaceuticals, Inc. Common Stock position peaked at $448K in Q3 2018.
65 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.